CVE-2018-14789

Description

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.

Category

6.7
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.09%
Vendor Advisory philips.com
Affected: Philips IntelliSpace Cardiovascular (ISCV) products
Published at:
Updated at:

References

Link Tags
https://www.usa.philips.com/healthcare/about/customer-support/product-security vendor advisory
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2018-14789?
CVE-2018-14789 has been scored as a medium severity vulnerability.
How to fix CVE-2018-14789?
To fix CVE-2018-14789, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-14789 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-14789 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-14789?
CVE-2018-14789 affects Philips IntelliSpace Cardiovascular (ISCV) products.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.